Wayne Bond Lau Selected Research

Wayne Bond Lau Research Topics

Disease

20	Myocardial Ischemia (Ischemic Heart Diseases) 01/2020 - 02/2009
16	Reperfusion Injury 01/2020 - 02/2009
13	Infarction (Infarctions) 01/2020 - 03/2009
10	Myocardial Infarction 01/2021 - 02/2009
10	Neoplasms (Cancer) 01/2020 - 05/2015
8	Heart Failure 11/2023 - 07/2011
6	Hypoxia (Hypoxemia) 01/2022 - 12/2011
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2016
5	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
5	Obesity 06/2017 - 09/2010
4	Insulin Resistance 11/2023 - 10/2010
4	Fibrosis (Cirrhosis) 09/2020 - 01/2015
4	Ischemia 10/2018 - 03/2009
3	Heart Injuries 01/2020 - 02/2009
3	Atherosclerosis 01/2017 - 10/2011
3	Poisoning 07/2016 - 04/2014
3	Pre-Eclampsia (Preeclampsia) 05/2015 - 09/2012
2	Vascular System Injuries 06/2022 - 09/2010
2	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2017
2	Cardiomegaly (Heart Hypertrophy) 12/2020 - 07/2011
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2020 - 12/2011
2	Inflammation (Inflammations) 01/2019 - 12/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 06/2017 - 10/2011
2	Colorectal Neoplasms (Colorectal Cancer) 02/2017 - 05/2015
2	Type 2 Diabetes Mellitus (MODY) 08/2015 - 12/2011
2	Vascular Ring 03/2014 - 03/2009
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2012 - 10/2010
2	Wounds and Injuries (Trauma) 08/2011 - 05/2011
1	Diabetic Angiopathies (Diabetic Angiopathy) 12/2023
1	Hypoadiponectinemia 12/2023
1	Prediabetic State (Prediabetes) 11/2023
1	Ischemic Stroke 11/2022
1	Cardiotoxicity 09/2020
1	Obstructive Sleep Apnea 01/2020
1	Carcinoma (Carcinomatosis) 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018

Drug/Important Bio-Agent (IBA)

21	AdiponectinIBA 12/2023 - 02/2009
16	Proteins (Proteins, Gene)FDA Link 12/2023 - 03/2009
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 09/2010
5	Insulin (Novolin)FDA Link 11/2023 - 10/2010
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Caveolin 3IBA 11/2023 - 04/2012
4	Caspase 3 (Caspase-3)IBA 01/2021 - 02/2009
4	CytokinesIBA 01/2019 - 06/2013
4	AMP-Activated Protein KinasesIBA 01/2019 - 02/2009
4	AutoantibodiesIBA 01/2019 - 09/2012
4	AdipokinesIBA 06/2017 - 08/2011
3	Adiponectin ReceptorsIBA 01/2022 - 09/2011
3	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2011
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 09/2009
3	ParaquatIBA 07/2016 - 01/2015
3	Type 1 Angiotensin ReceptorIBA 05/2015 - 09/2012
3	Glucose (Dextrose)FDA LinkGeneric 07/2014 - 07/2009
3	Superoxides (Superoxide)IBA 01/2013 - 03/2009
2	Protein Isoforms (Isoforms)IBA 11/2022 - 01/2015
2	Sevoflurane (Ultane)FDA LinkGeneric 01/2020 - 09/2013
2	CateninsIBA 01/2020 - 01/2020
2	withaferin AIBA 01/2019 - 10/2018
2	Anesthetics (Anesthetic Agents)IBA 01/2019 - 09/2013
2	RNA (Ribonucleic Acid)IBA 01/2018 - 02/2017
2	Long Noncoding RNAIBA 02/2017 - 01/2017
2	AdipoRonIBA 01/2017 - 08/2015
2	EnzymesIBA 01/2017 - 11/2016
2	Triglycerides (Triacylglycerol)IBA 11/2016 - 09/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2016 - 03/2009
2	IntegrinsIBA 01/2016 - 09/2009
2	Messenger RNA (mRNA)IBA 01/2015 - 12/2011
2	Peroxidase (Myeloperoxidase)IBA 07/2014 - 02/2009
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2013 - 01/2013
2	Lymphotoxin-alpha (Lymphotoxin)IBA 03/2013 - 01/2013
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2013 - 03/2009
2	ThioredoxinsIBA 09/2010 - 07/2009
1	PhosphotyrosineIBA 12/2023
1	Inhibitor of Apoptosis ProteinsIBA 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	CaspasesIBA 01/2021
1	Nicotine FDA Link 09/2020
1	salicylhydroxamic acid (SHAM)IBA 09/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	CM-DiIIBA 01/2020
1	H-cadherin (T-cadherin)IBA 01/2020
1	Cadherins (E-Cadherin)IBA 01/2020
1	CatecholaminesIBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2018
1	erteberelIBA 01/2018
1	AcetyltransferasesIBA 01/2018
1	DisulfidesIBA 01/2018
1	Histones (Histone)IBA 01/2018
1	MethyltransferasesIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2018
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2018
1	3' Untranslated Regions (3' UTR)IBA 01/2018
1	Untranslated Regions (Untranslated Region)IBA 01/2018
1	CalreticulinIBA 01/2018
1	Therapeutic UsesIBA 01/2018
1	Estrogen Receptor betaIBA 01/2018

Therapy/Procedure

8	Therapeutics 01/2022 - 08/2013
2	Ligation 01/2013 - 09/2010